Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)
Clinical trial NCT02145182 · COMPLETED
Trial details
- NCT number
- NCT02145182
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-21
- Primary completion
- 2016-11-22
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.